In patients with breast cancer, a high incidence of pathogenic variants of BRCA1 and BRCA2 is observed, as well as other highly mutated genes, such as PALB2, CHEK2, MUTYH, and ATM [3]. This evidence concerns the gene ATM and breast carcinoma.